ASX:HLS Healius (HLS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Healius Stock (ASX:HLS) 30 days 90 days 365 days Advanced Chart Get Healius alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.33 million shsAverage VolumeN/AMarket CapitalizationA$1.01 billionP/E RatioN/ADividend Yield4.46%Price TargetN/AConsensus RatingN/A Company Overview Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia. Read More Receive HLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter. Email Address HLS Stock News HeadlinesMUFG Acquires Substantial Holding in Healius LimitedJune 24, 2025 | tipranks.comHealius Limited Strengthens Leadership with New Company Secretary AppointmentMay 29, 2025 | tipranks.comThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.July 7 at 2:00 AM | Crypto Swap Profits (Ad)Spheria Reduces Stake in Healius LimitedMay 9, 2025 | tipranks.comHealius Limited Declares Special Dividend and Secures New Debt FacilityMay 4, 2025 | tipranks.comHealius Limited Announces New Dividend DistributionMay 4, 2025 | tipranks.comHealius Limited Updates CEO Employment Terms and Incentive StructureApril 27, 2025 | tipranks.comHealius Limited Finalizes Sale of Lumus Imaging to Affinity Equity PartnersApril 17, 2025 | tipranks.comSee More Headlines HLS Stock Analysis - Frequently Asked Questions How were Healius' earnings last quarter? Healius Limited (ASX:HLS) released its earnings results on Friday, February, 15th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.06. Healius had a negative trailing twelve-month return on equity of 61.77% and a negative net margin of 36.98%. What other stocks do shareholders of Healius own? Based on aggregate information from My MarketBeat watchlists, some other companies that Healius investors own include bluebird bio (BLUE), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU), Esperion Therapeutics (ESPR), Fortress Biotech (FBIO) and Forte Biosciences (FBRX). Company Calendar Last Earnings2/15/2019Ex-Dividend for 5/22 Dividend5/08/2025Record date for 5/22 Dividend5/22/2025Dividend Payable5/22/2025Today7/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:HLS CIKN/A Webwww.primaryhealthcare.com.au Phone61 2 9432 9400FaxN/AEmployees10,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.94Net Income-A$636 million Net Margins-36.98% Pretax MarginN/A Return on Equity-61.77% Return on Assets1.23% Debt Debt-to-Equity Ratio153.54 Current Ratio0.50 Quick Ratio0.47 Sales & Book Value Annual SalesA$1.75 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow12.26 Book ValueA$0.88 per share Price / BookN/AMiscellaneous Outstanding Shares726,130,000Free FloatN/AMarket CapA$1.01 billion OptionableNot Optionable Beta0.73 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (ASX:HLS) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Healius Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Healius With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.